Literature DB >> 17084902

Fluconazole susceptibility testing of Candida species by flow cytometry.

Young Hee Joung1, Hye Ryoun Kim, Mi Kyung Lee, Ae Ja Park.   

Abstract

OBJECTIVE: Currently, antifungal drug susceptibility testing is labor-intensive, limited by delays in obtaining results and high costs. The purpose of this study was to determine the usefulness of flow cytometry (FCM) antifungal drug susceptibility testing as a routine laboratory procedure.
METHODS: A total of 24 clinical isolates of Candida spp. and reference strains were tested for susceptibility to fluconazole by FCM using propidium iodide (PI) as an indicator of viability. The minimum inhibitory concentration (MIC) was defined as the lowest concentration of fluconazole that resulted in an increase of 30% in mean channel fluorescence (MCF), compared to the growth control. FCM results were compared with MIC results as determined by the Clinical and Laboratory Standards Institute (CLSI) method.
RESULTS: An 8h incubation was sufficient for determination of the MICs. The results by FCM at 8h and the NCCLS methods at 24h showed 87.5% agreement to within two drug dilutions. However, the FCM method is labor-intensive in proportion to the larger number of samples. For Candida lusitaniae, MICs by the FCM method showed poor correlation with the CLSI method.
CONCLUSIONS: Further evaluation is necessary to assess the usefulness of FCM as a technique for routine antifungal MIC testing in the clinical laboratory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084902     DOI: 10.1016/j.jinf.2006.09.016

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

1.  In vitro antifungal activity of hydroxychavicol isolated from Piper betle L.

Authors:  Intzar Ali; Farrah G Khan; Krishan A Suri; Bishan D Gupta; Naresh K Satti; Prabhu Dutt; Farhat Afrin; Ghulam N Qazi; Inshad A Khan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-02-03       Impact factor: 3.944

2.  Synergistic effect of the flavonoid catechin, quercetin, or epigallocatechin gallate with fluconazole induces apoptosis in Candida tropicalis resistant to fluconazole.

Authors:  Cecília Rocha da Silva; João Batista de Andrade Neto; Rosana de Sousa Campos; Narjara Silvestre Figueiredo; Letícia Serpa Sampaio; Hemerson Iury Ferreira Magalhães; Bruno Coêlho Cavalcanti; Danielle Macêdo Gaspar; Geanne Matos de Andrade; Iri Sandro Pampolha Lima; Glauce Socorro de Barros Viana; Manoel Odorico de Moraes; Marina Duarte Pinto Lobo; Thalles Barbosa Grangeiro; Hélio Vitoriano Nobre Júnior
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

3.  Synergistic effects of amiodarone and fluconazole on Candida tropicalis resistant to fluconazole.

Authors:  Cecília Rocha da Silva; João Batista de Andrade Neto; José Júlio Costa Sidrim; Maria Rozzelê Ferreira Angelo; Hemerson Iury Ferreira Magalhães; Bruno Coêlho Cavalcanti; Raimunda Sâmia Nogueira Brilhante; Danielle Silveira Macedo; Manoel Odorico de Moraes; Marina Duarte Pinto Lobo; Thalles Barbosa Grangeiro; Hélio Vitoriano Nobre Júnior
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

4.  Susceptibility tests of oropharyngeal Candida albicans from egyptian patients to fluconazole determined by three methods.

Authors:  Noha El-Mashad; Mona F Foad; Niveen Saudy; Dalia A Salem
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

5.  Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis.

Authors:  João B A Neto; Cecília R da Silva; Maria A S Neta; Rosana S Campos; Janaína T Siebra; Rose A C Silva; Danielle M Gaspar; Hemerson I F Magalhães; Manoel O de Moraes; Marina D P Lobo; Thalles B Grangeiro; Tatiane S C Carvalho; Emilay B T Diogo; Eufrânio N da Silva Júnior; Felipe A R Rodrigues; Bruno C Cavalcanti; Hélio V N Júnior
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.